Literature DB >> 26072075

Expressions of E-cadherin, p120ctn, β-catenin and NF-κB in ulcerative colitis.

Chao Zhang1, Li-Wei Liu1, Wen-Jia Sun1, Sheng-Hui Qin1, Ling-Zhi Qin1, Xi Wang2.   

Abstract

This study was aimed to investigate the expressions of E-cadherin, p120ctn, β-catenin and NF-κB in ulcerative colitis (UC) tissues and the implications of their expressions in the pathogenesis of UC. The expressions of E-cadherin, p120ctn, β-catenin and NF-κB were detected by immunohistochemistry, and those of p120ctn and NF-κB by Western blotting in 23 cases of UC and 17 cases of normal colonic tissues. The relationship between the expression of E-cadherin or NF-κB and that of p120ctn was analyzed by Spearman rank correlation analysis. The results showed that in UC and normal colonic groups, the abnormal expression rate of E-cadherin, p120ctn, β-catenin, and NF-κB was 52.2% vs. 0 (P<0.05), 73.9% vs. 23.5% (P<0.05), 65.2% vs. 17.6% (P<0.05) and 78.4% vs. 23.5% (P<0.05), respectively. p120ctn expression was positively correlated with E-cadherin expression (r=0.404, P<0.05), but negatively with nuclear NF-κB expression (r= - 0.347, P<0.05). Western blotting showed that as compared with the normal controls, the p120ctn protein level was significantly decreased (P<0.05), whereas the NF-κB protein level was increased (P<0.05) in UC tissues. It was concluded that in the colonic tissues of UC patients, the expressions of E-cadherin, p120ctn and β-catenin are decreased, suggesting the mucosal barrier is impaired in UC. Moreover, NF-κB is increased and activated in the UC tissues, resulting in the inflammation in UC. p120ctn may influence the UC development through modulating intercellular adhesion and inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26072075     DOI: 10.1007/s11596-015-1439-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  25 in total

1.  Involvement of p120 in LPS-induced NF-kappaB activation and IL-8 production in human bronchial epithelial cells.

Authors:  Manxiang Wang; Naping Li; Jiansha Li; Yan Ma; Dan Li; Lingzhi Qin; Xi Wang; Renliang Wu
Journal:  Toxicol Lett       Date:  2010-02-19       Impact factor: 4.372

Review 2.  NF-kappaB and the intestine: friend or foe?

Authors:  Thomas Karrasch; Christian Jobin
Journal:  Inflamm Bowel Dis       Date:  2008-01       Impact factor: 5.325

Review 3.  Cadherin-mediated cell-cell adhesion and signaling in the skeleton.

Authors:  Pierre J Marie; Eric Haÿ; Dominique Modrowski; Leila Revollo; Gabriel Mbalaviele; Roberto Civitelli
Journal:  Calcif Tissue Int       Date:  2013-05-09       Impact factor: 4.333

4.  Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer.

Authors:  Mirna Perez-Moreno; Weimin Song; H Amalia Pasolli; Scott E Williams; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

Review 5.  Role of NF-kappaB in immune and inflammatory responses in the gut.

Authors:  M F Neurath; C Becker; K Barbulescu
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice.

Authors:  Whitney G Smalley-Freed; Andrey Efimov; Patrick E Burnett; Sarah P Short; Michael A Davis; Deborah L Gumucio; M Kay Washington; Robert J Coffey; Albert B Reynolds
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

Review 7.  NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.

Authors:  Laurence J Egan; Murat Toruner
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

8.  Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion.

Authors:  Noboru Ishiyama; Seung-Hye Lee; Shuang Liu; Guang-Yao Li; Matthew J Smith; Louis F Reichardt; Mitsuhiko Ikura
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 9.  Deep remission in inflammatory bowel disease: looking beyond symptoms.

Authors:  Camille Zallot; Laurent Peyrin-Biroulet
Journal:  Curr Gastroenterol Rep       Date:  2013-03

10.  Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease.

Authors:  M F Neurath; I Fuss; G Schürmann; S Pettersson; K Arnold; H Müller-Lobeck; W Strober; C Herfarth; K H Büschenfelde
Journal:  Ann N Y Acad Sci       Date:  1998-11-17       Impact factor: 5.691

View more
  4 in total

Review 1.  Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.

Authors:  Susana Lechuga; Andrei I Ivanov
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-03-18       Impact factor: 4.739

2.  NF-kappa B activation correlates with disease phenotype in Crohn's disease.

Authors:  Yoo Min Han; Jaemoon Koh; Ji Won Kim; Changhyun Lee; Seong-Joon Koh; ByeongGwan Kim; Kook Lae Lee; Jong Pil Im; Joo Sung Kim
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

3.  miR-223 promotes colon cancer by directly targeting p120 catenin.

Authors:  Liwei Liu; Chao Zhang; Xiyu Li; Wenjia Sun; Shenghui Qin; Lingzhi Qin; Xi Wang
Journal:  Oncotarget       Date:  2017-07-25

Review 4.  Functions of EpCAM in physiological processes and diseases (Review).

Authors:  Li Huang; Yanhong Yang; Fei Yang; Shaomin Liu; Ziqin Zhu; Zili Lei; Jiao Guo
Journal:  Int J Mol Med       Date:  2018-07-11       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.